These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30283822)

  • 41. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Sep; 83(189):48950-3. PubMed ID: 30272400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opportunities, Challenges, and Scientific Progress in Hemp Crops.
    Kaminski KP; Hoeng J; Goffman F; Schlage WK; Latino D
    Molecules; 2024 May; 29(10):. PubMed ID: 38792258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations.
    Pavlovic R; Nenna G; Calvi L; Panseri S; Borgonovo G; Giupponi L; Cannazza G; Giorgi A
    Molecules; 2018 May; 23(5):. PubMed ID: 29783790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cannabidiol goes nuclear: The role of PPARγ.
    Khosropoor S; Alavi MS; Etemad L; Roohbakhsh A
    Phytomedicine; 2023 Jun; 114():154771. PubMed ID: 36965374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study.
    Kongkadee K; Wisuitiprot W; Ingkaninan K; Waranuch N
    Arch Oral Biol; 2022 Aug; 140():105464. PubMed ID: 35623115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies.
    Sholler DJ; Schoene L; Spindle TR
    Curr Addict Rep; 2020 Sep; 7(3):405-412. PubMed ID: 33585159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.
    Sekar K; Pack A
    F1000Res; 2019; 8():. PubMed ID: 30854190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Δ
    Babalonis S; Raup-Konsavage WM; Akpunonu PD; Balla A; Vrana KE
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):362-365. PubMed ID: 34662224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
    Shover CL; Humphreys K
    Cureus; 2020 Jun; 12(6):e8671. PubMed ID: 32699671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabidiol: pharmacology and therapeutic targets.
    Britch SC; Babalonis S; Walsh SL
    Psychopharmacology (Berl); 2021 Jan; 238(1):9-28. PubMed ID: 33221931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the 4-aminophenol color test for the differentiation of marijuana-type and hemp-type cannabis.
    Lewis K; Wagner R; Rodriguez-Cruz SE; Weaver MJ; Dumke JC
    J Forensic Sci; 2021 Jan; 66(1):285-294. PubMed ID: 32956496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory sampling of industrial hemp plant samples (Cannabis sativa L.) using UPLC-MS/MS method for detection and quantification of twelve cannabinoids.
    Berthold EC; Yang R; Sharma A; Kamble SH; Kanumuri SR; King TI; Popa R; Freeman JH; Brym ZT; Avery BA; McCurdy CR
    J Cannabis Res; 2020 Dec; 2(1):42. PubMed ID: 33526142
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Gildea L; Ayariga JA; Ajayi OS; Xu J; Villafane R; Samuel-Foo M
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations and Implications of Cannabidiol Use During Pregnancy.
    Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C
    Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.
    Skinner CM; Nookaew I; Ewing LE; Wongsurawat T; Jenjaroenpun P; Quick CM; Yee EU; Piccolo BD; ElSohly M; Walker LA; Gurley B; Koturbash I
    J Diet Suppl; 2020; 17(5):543-560. PubMed ID: 32400224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is cannabidiol a scheduled controlled substance? Origin makes the difference.
    Citti C; Linciano P; Cannazza G
    Drug Discov Today; 2020 Apr; 25(4):628-632. PubMed ID: 32062008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
    Hurd YL; Yoon M; Manini AF; Hernandez S; Olmedo R; Ostman M; Jutras-Aswad D
    Neurotherapeutics; 2015 Oct; 12(4):807-15. PubMed ID: 26269227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog.
    Citti C; Linciano P; Forni F; Vandelli MA; Gigli G; Laganà A; Cannazza G
    J Pharm Biomed Anal; 2019 Oct; 175():112752. PubMed ID: 31330283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CBD Retailers in NC Promote CBD Online to Treat Pain Violating FDA Rules About Medical Claims and Offer Low-CBD/High-Price Products.
    Amann L; Kruse E; Lazard AJ; Reboussin BA; Wagoner KG; Romero-Sandoval EA
    J Pain Res; 2022; 15():3847-3858. PubMed ID: 36514481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.